← All trials
NCT00311220
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2004
- Primary completion
- —
- Completion date
- Nov 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Taichung Veterans General HospitalLead sponsor
- Taichung Veterans General HospitalOverall official - principal investigator
- ChungHwa Veterans houseCollaborator
- National Taiwan UniversityCollaborator
- Centers for Disease Control and Prevention (CDC)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.